System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Adam Kobayashi is an expert in Neurology at Institute of Psychiatry and Neurology (Poland). As of October 2026, ScienceLeadR ranks Adam Kobayashi in the top 1% of experts in Poland for Cerebrovascular Disorders. Adam Kobayashi has authored 122 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 1 of them ongoing. SLR score: 295 (community average: 125). How the SLR is computed.

LeadR Profile

Adam Kobayashi Institute of Psychiatry and Neurology Poland
295 ScienceLeadR Reputation 295

Unlock

Register Login
Network Map

Neurology

Subspecialties: Internal Medicine - Neurosurgery - Cardiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2001 - 2026
Source: PubMed

Institute of Psychiatry and Neurology

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 122

Citations

Citations: 5 507 1st author: 13 Last author: 7 Unique author: 1

Main journals

Stroke 19
Neurol Neurochir Pol 17
Int J Stroke 14
Eur Stroke J 8
J Neurol Sci 4

Best Journals

Lancet 2
Circulation 1
Eur Heart J 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Comparative external validation of ICH prognostic scores for discharge outcomes in the RES-Q multinational quality registry.
PMID 42717488 — registries, mortality, stroke		Eur Stroke J20260
Very Early Short-Course Cerebrolysin After Tenecteplase and Mechanical Thrombectomy: A Case Report.
PMID 42666484 — stroke, rehabilitation, reperfusion, reperfusion injury, tenecteplase, therapeutics, thrombectomy		Case Rep Neurol Med20260
Pharmacogenetics in Community Pharmacy: Global Perspectives and Implementation.
PMID 42123011 — genes, genomics, pharmacogenetics, safety, genetics, pharmaceutical preparations, pharmacists, pharmacy, drug therapy, pharmacology, physicians, therapeutics		J Clin Med20260
Time-Dependent Efficacy of Thrombolysis Before Thrombectomy: Registry of Stroke Care Quality (RES-Q).
PMID 42089412 — registries, stroke, cerebrovascular disorders, therapeutics, thrombectomy		Stroke20260
Status on stroke and stroke care in Europe 2023: Stroke Service Tracker 2023 data based on 1,460,360 strokes in 47 European nations.
PMID 41712681 — epidemiology, stroke, economic factors, socioeconomic factors		Eur Stroke J20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 2
Phase 3 1
Phase 4 1

By status:

Completed 2
Not yet recruiting 1
Terminated 1

By type:

Interventional 3
Observational 1

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 1
multicentricup10 1

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Safety and Feasibility of Using Cerebrolysin in the Treatment of Primary Intracerebral Hemorrhage a Prospective Randomized Open Blinded End point Trial
NCT06899464 — cerebral hemorrhage, safety, hemorrhage, stroke, hemorrhagic stroke, neuroprotection, therapeutics		Phase 4Not yet recruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS